Introduction DCDOH supports HIV test and treat activities - increased number of HIV tests performed, emphasis on earlier linkage to care. Limited data.

Slides:



Advertisements
Similar presentations
MINNESOTAS HIV TREATMENT CASCADE. Introduction This slide set describes the continuum of HIV care in Minnesota. The slides rely on data from HIV/AIDS.
Advertisements

Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Cascade The Continuum of HIV Care Florida, 2012 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2012, as of 06/30/2013.
Cascade The Continuum of HIV Care Florida, 2013 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2013, as of 06/30/2014.
Wisconsin HIV/AIDS Surveillance Annual Review: Slide Set New diagnoses, prevalent cases, and deaths through December 2014 April 2015 P Wisconsin.
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
HIV Care Continuum, Men Who Have Sex with Men Only (MSMO) and Men Who Have Sex with Men and Women (MSMW), Georgia, 2012.
Late HIV Diagnoses, Georgia,
HIV Mortality for Florida and the Six (EMAs) Eligible Metropolitan Areas Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease.
HIV Disease in Older Patients Donna M. Gallagher, ANP The International AIDS Society–USA DM Gallagher, ANP. Presented at IAS–USA/RWCA Clinical Conference,
HIV Mortality in Florida 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control and Health Protection Death data.
The Internet: An Emerging Venue for Syphilis Epidemics Among Men Who Have Sex with Men in Los Angeles LAC - DHS Getahun Aynalem, MD, MPH, Kellie Hawkins,
Patients in routine HIV clinical care at-risk for potentially transmitting HIV in the “test and treat” era of HIV prevention Crane, HM, Mimiaga, M, Feldman,
1 Predictors of Retention in Care Among HIV+ and At-Risk Youth Sion Kim Harris, PhD Cathryn L. Samples, MD, MPH Peter Keenan, RN, C-PNP Durrell J. Fox,
Patient Empowerment Impacts Medication Adherence among HIV-Positive Patients in the Veteran’s Health Administration Tan Pham 1,2,3, Kristin Mattocks 1,2,
Ways to Analyze Data to Monitor Progress on the National HIV/AIDS Strategy Angelique Griffin, MS DC Department of Health HIV/AIDS, Hepatitis, STD and TB.
The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected Persons The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Association between area- level poverty and HIV diagnoses, and differences by sex, New York City Ellen Wiewel, HIV Epidemiology & Field Services.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
Skull Base Chordoma and Chondrosarcoma: Changes in National Radiotherapy Patterns and Survival Outcomes Henry S. Park, MD, MPH; Kenneth B. Roberts, MD;
Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Universidad Central del Caribe Comorbidity and HIV Risk Behaviors among Hispanic Drug Users Residing in Puerto Rico Oral Presentation.
Determination of HIV Infection Among TB Patients in California, 2008 Darryl Kong 1, Jennifer Flood 1, Suzanne Marks 2, James Watt 1 1 California Department.
HIV Care Continuum, District 8- 2 Southwest (Albany), Georgia, 2012.
HIV/AIDS among Women in Texas Enhanced Perinatal Surveillance May 30, 2007 Nita Ngo, MPH.
Older and wiser: continued improvements in clinical outcome and highly active antiretroviral therapy (HAART) response in HIV-infected children in the UK.
RESULTS Individual characteristics % (N) unless otherwise specified Gender Male 65% (255) Female 35% (136) Race/Ethnicity African American 35% (137) White-not.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
HSV-2 is associated with HIV acquisition among both placebo & vaccine recipients in the Step Study Ruanne V Barnabas, MBChB DPhil HIV Vaccine Trials Network,
HIV Mortality for Florida and the Six (EMAs) Eligible Metropolitan Areas Florida Department of Health HIV/AIDS & Hepatitis Program Death data as of 07/12/2012.
#735 KA Lichtenstein 1, C Armon 2, K Buchacz 3, AC Moorman 3, KC Wood 2, JT Brooks 3, and the HOPS Investigators 1 University of Colorado Health Sciences.
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
Generously supported by the Robert Wood Johnson Foundation Clinical Scholars Program, Department of Veteran Affairs, and National Institutes of Health,
Neurocognitive Impairment in HIV-Infected Subjects on HAART: Prevalence and Associations Kevin Robertson *1, Kunling Wu 2, Thomas Parsons 1, Ron Ellis.
David Dowdy, Elvin Geng, Katerina Christopoulos, James Kahn, C. Bradley Hare, Daniel Wlodarczyk, Diane Havlir Internal Medicine Residency Program, UCSF.
Engagement in the HIV care cascade among transgender women enrolled in a public HIV clinic in Buenos Aires, Argentina, M.E. Socías 1,2, O. Sued.
Arnold School of Public Health Health Services, Policy, and Management 1 Drug Treatment Disparities Among African Americans Living with HIV/AIDS Carleen.
4th June 2012 Nisha Kini Disparities in Heart Attack Knowledge by Gender, Race/Ethnicity, Education Level and Household Income among Maine adults.
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
HIV Care Continuum, District 10 Northeast (Athens), Georgia, 2012.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
1 The impact of ongoing illicit drug use on virologic suppression in HIV-infected injection drug users receiving HAART Authors: Harout Tossonian, Jesse.
Supported by: NIAID/NHLBI R24 AI067039, NIAID R21 AI Viremia copy-years: A measure of cumulative HIV burden among patients initiating antiretroviral.
CEACEA CENTROCENTRO DE ESTUDIOS EN ADICCION Testing an Intervention Model to Reduce HIV/AIDS Among Hispanic Drug Users Residing in Puerto Rico Robles RR,
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Addressing Racial/Ethnic Differences in ADHD Diagnosis and Treatment Among Medicaid-insured Youth in California Dinci Pennap, MPH, 1 Mehmet Burcu, MS,
The Continuum of HIV Care Florida, 2014 The Continuum of HIV Care Florida, 2014 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2014, as of.
HIV Infection Among Those with an Injection Drug Use*-Associated Risk, Florida, 2014 Florida Department of Health HIV/AIDS Section Division of Disease.
MINNESOTA’S HIV TREATMENT CASCADE April, Introduction.
Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,
Epidemiology of HIV Among Men in Florida, Reported through 2014 Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection.
The Impact of Darunavir/ritonavir (DRV/r) & Raltegravir (RAL) in the Clinic: A New Era for Treatment-Experienced Patients? M. Mugavero 1, H. Lin 1, J.
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
Viral load distribution 2012 among persons living with HIV and persons newly diagnosed Georgia, 2011.
Figure 2: Trends in currently prescribed antiretroviral therapy % prescribed HAART increased from 74% to 83% Trends in ART use, HIV viral load, and CD4.
Housing Status and HIV Risk Behaviors Among Homeless and Housed Persons with HIV in the United States The findings and conclusions in this presentation.
HIV in America What’s New in 2012 Christopher Hurt, MD Clinical Assistant Professor NC AIDS Education and Training Center 2012 HIV Update.
Estimating the population impact of homelessness on HIV viral suppression among people who use drugs Brandon DL Marshall, 1 Beth Elson, 1 Sabina Dobrer,
Summary of HIV Infection in Alaska, 1982–2015 Prepared by the State of Alaska Department of Health and Social Services, Division of Public Health, HIV/STD.
HIV Epidemiological Profile for Chicago EMA
Conclusions & Implications
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
Amanda D. Castel, MD, MPH Assistant Research Professor
San Francisco Department of Public Health
Poster WP41; Contact: David A. Katz,
Shawn L Fultz, MD MPH VACS Scientific Meeting, Feb 2004
M Javanbakht, S Guerry, LV Smith, P Kerndt
Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD
Presentation transcript:

Introduction DCDOH supports HIV test and treat activities - increased number of HIV tests performed, emphasis on earlier linkage to care. Limited data about the impact of these efforts on viral suppression (VS). This analysis identified factors associated with achieving VS among a cohort of newly diagnosed HIV/AIDS cases. Methods Eligibility: HIV/AIDS cases diagnosed , initial detectable VL followed by at least 1 additional VL test before 12/31/10. VS was defined as <400 copies/mL Performed bivariate analyses, multivariate LR and survival analyses to determine predictors of viral suppression. Results 2,412 cases diagnosed between ; 988 met eligibility criteria. 648 of eligible cases achieved VS prior to 12/31/2010. Factors associated with achieving viral suppression among newly diagnosed HIV/AIDS cases in Washington, D.C Willis SJ, Castel AD, Griffin A, West T, Shaikh I, Pappas G

Continuous Care At least 2 VL tests per year vs. less than 2 VL tests per year AIDS vs. HIV, not AIDS Other race vs. White Hispanic vs. White Black vs. White Male vs. Female vs vs vs Multivariate Logistic Regression† Results No difference in median VL at diagnosis (achieved VS: 22,583.5 copies/mL; no VS: 18,444.0 copies/mL, p=0.42) Individuals ≥50 yrs were 2.0 times as likely to achieve VS than yr olds. AIDS diagnoses were 1.7 times as likely to achieve VS than individuals diagnosed with HIV, not AIDS. Individuals with 2+ VL tests/yr were 7.4 times as likely to achieve VS than individuals with <2 VL tests/yr. † Odds ratio adjusted for sex, race/ethnicity, age at diagnosis, diagnostic status, continuous care, and annual viral load test rate

Adjusted Cox Proportional Hazards Ratio (95% CI)† Sex Males vs. Females 1.08 (0.91, 1.28) Race/Ethnicity White vs. all other races 1.04 (0.82, 1.32) Age at HIV diagnosis ≥ 50 years vs years 1.49 (1.22, 1.82) Diagnostic status AIDS vs. HIV, not AIDS 1.45 (1.22, 1.74) Linkage to care ≤ 3 months vs. > 3 months 1.22 (1.01, 1.47) Continuous care Continuous vs. not continuous 1.40 (1.178, 1.66) Annual VL test rate At least 2 VL tests per year vs. less than 2 VL tests per year 3.21 (2.72, 3.78) Conclusions Engagement in care is directly associated with VS. Individuals that are immunosuppressed at diagnosis are more likely to achieve VS - motivated to seek care, adhere to treatment, provider behavior Individuals ≥50 years of age at diagnosis more likely to achieve VS. Programs that emphasize engagement in care are crucial to improving health of HIV-infected persons. Bolded values represent statistically significant values. †Cox Proportional Hazards Ratios were adjusted for sex, race/ethnicity, age at HIV diagnosis, diagnostic status, linkage to care, continuous care, and annual VL test rate.